Please login to the form below

Not currently logged in
Email:
Password:

Fishawack appoints John Handley as new chairman

He joins to support UK group's acquisition plans

John Handley UK-based Fishawack has appointed John Handley as its new chairman in a move the communications agency group said will support its acquisition plans.

Handley has extensive experience of chairing companies backed by private equity investors and also lectures on behalf of the British Venture Capital Association.

He joins a group that has already struck a number of deals this year, acquiring Swiss medical communications agency Archimed and the US-based shop JK Associates.

“I have been impressed by the rate of growth that the Fishawack team has achieved over the past few years,” Handley said. “This has been both through acquisition and organically within the individual companies, but with effective consolidation and without losing the Group's specialist focus.

“I can see the further potential that the management team has identified in their strategic growth plan and anticipate a productive relationship creating further value in the business.”

Fishawack currently has a team of over 220, based at offices in the UK, the US and Switzerland.

17th June 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....